Krystal Biotech

-$1.54 (-2.65%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases.

CEO
Krish S. Krishnan
Employees
75
Headquarters
Pittsburgh, Pennsylvania
Founded
2016

KRYS Key Statistics

Market Cap
1.42B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
165.07K
High Today
$59.03
Low Today
$56.02
Open Price
$57.80
Volume
47.80K
52 Week High
$87.29
52 Week Low
$39.39

KRYS Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure